Generic Medicine Info
Special Precautions
Pregnancy and lactation. Monitoring Parameters Perform culture and susceptibility tests or confirm diagnosis via direct microscopic examination of a KOH mounting of infected tissue; consult local institutional recommendations before treatment initiation due to antifungal resistance risks. Monitor for signs of application site reactions (e.g. exfoliation, erythema, dermatitis).
Adverse Reactions
Significant: Irritation, sensitivity. General disorders and administration site conditions: Application site reactions. Skin and subcutaneous tissue disorders: Burning, stinging sensation of the skin; dryness, erythema, itching.
ATC Classification
D01AE22 - naftifine ; Belongs to the class of other antifungals for topical use.
Disclaimer: This information is independently developed by CIMS based on naftifine from various references and is provided for your reference only. Therapeutic uses, prescribing information and product availability may vary between countries. Please refer to CIMS Product Monographs for specific and locally approved prescribing information. Although great effort has been made to ensure content accuracy, CIMS shall not be held responsible or liable for any claims or damages arising from the use or misuse of the information contained herein, its contents or omissions, or otherwise. Copyright © 2021 CIMS. All rights reserved. Powered by
Register or sign in to continue
Asia's one-stop resource for medical news, clinical reference and education
Sign up for free
Already a member? Sign in